2.1 Million Cardiac Rhythm Patients in Indonesia Spikes the Beat of the CRM Market, Finds Frost & Sullivan

2.1 Million Cardiac Rhythm Patients in Indonesia Spikes the Beat of the CRM Market, Finds Frost & Sullivan PR Newswire JAKARTA, Indonesia, June 20, 2012 - Pacemakers Emerge the Most Popular Device with 49.6 Per cent of the Sales, Closely Followed by Cardiac Ablation with 42.2 Per cent JAKARTA, Indonesia, June 20, 2012 /PRNewswire/ -- Indonesia has a high prevalence of both communicable and non-communicable diseases; among non-communicable diseases, cardiovascular disease's incidence is 7.2 per cent of the total population of 247 million and it is also the fourth leading cause of mortality. Of these, 2.1 million suffer from disorders caused by the rhythm of heart, signifying vast opportunities for the cardiac rhythm management (CRM) market on a small base. New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), Indonesian Market for Cardiac Rhythm Management, finds that the market earned revenues of $1.75 million in 2011 and estimates this to reach $4.15 million in 2016 at a compound annual growth rate of 18.9 per cent. The occurrence of cardiovascular diseases is on the rise due to sedentary lifestyles, unhealthy eating habits and urbanization. However, changes in healthcare services legislation, revamp in health insurance policies, an aging population, affluent and dormant life style, smoking and the urge to be treated will boost the Indonesian CRM market.